0001209191-14-020862.txt : 20140317 0001209191-14-020862.hdr.sgml : 20140317 20140317112054 ACCESSION NUMBER: 0001209191-14-020862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140313 FILED AS OF DATE: 20140317 DATE AS OF CHANGE: 20140317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVY BRIAN CENTRAL INDEX KEY: 0001277458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 14696546 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-03-13 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001277458 LEVY BRIAN C/O AERIE PHARMACEUTICALS, INC. 135 U.S. HIGHWAY 206, SUITE 15 BEDMINSTER NJ 07921 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 20.70 2014-03-13 4 A 0 115000 0.00 A 2024-03-13 Common Stock 115000 115000 D This option was granted on March 13, 2014 and is scheduled to vest with respect to 25% of the underlying shares on March 13, 2015, and thereafter in 36 equal installments on each monthly anniversary of the date of grant. /s/ Richard J. Rubino, Attorney-in-Fact for Brian Levy 2014-03-17